SPECIAL REPORT on Aducanumab Approval: Steve Pearson of ICER Discusses the Economic and Clinical Impact
Neurology® Podcast · Sharon Quimby
June 17, 202130m 37s
Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Dr. Jason Crowell speaks with Dr. Steve Pearson, President of the Institute for Clinical and Economic Review, about the clinical and economic impact of aducanumab, a drug recently approved by the FDA for the treatment of Alzheimer disease.